Vivian H. Shih

机构：Insmed (United States) · ORCID：0000-0003-0853-4210

发表论文 43 篇 · 总被引 1207 次 · h-index 12

代表论文

• Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme (2024 · European Respiratory Journal · 被引 60)
• Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial (2025 · American Journal of Respiratory and Critical Care Medicine · 被引 21)
• XALOC-1 (2025 · CHEST Journal · 被引 15)
• Benralizumab in Severe Eosinophilic Asthma and Chronic Rhinosinusitis with Nasal Polyps: The Real-World, Multi-Country RANS Observational Study (2024 · Journal of Asthma and Allergy · 被引 15)
• Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia (2024 · Respiratory Medicine · 被引 14)
• Brensocatib in patients with bronchiectasis: subgroup analyses from the WILLOW trial (2024 · ERJ Open Research · 被引 12)